Apellis Announces Plans to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH) May 21, 2020 - NASDAQ Companies 0 Submission of New Drug ApplicationBay Street News » View More News for May 21, 2020